TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Bioaxter Bioscience AB
Closing information (x1000 NOK)
Closing information | 2021/12 | 2020/12 | 2019/12 |
Turnover |
0
![]() |
0
|
4,591 |
Financial expenses |
0
![]() |
0
|
13 |
Earnings before taxes |
-457
|
2,559
|
153 |
EBITDA |
-358
|
2,665
|
1,246 |
Total assets |
2,136
|
2,858
|
2,665 |
Current assets |
2,003
|
2,609
|
1,555 |
Current liabilities |
73
|
151
|
1,078 |
Equity capital |
2,063
|
2,707
|
1,433 |
- share capital |
49
|
52
|
47 |
Employees (average) |
1
![]() |
1
|
4 |
Financial ratios
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Solvency |
96.6%
|
94.7%
|
53.8% |
Turnover per employee |
0
![]() |
0
|
1,148 |
Profit as a percentage of turnover | 3.3% | ||
Return on assets (ROA) |
-21.4%
|
89.5%
|
6.2% |
Current ratio |
2743.8%
|
1727.8%
|
144.2% |
Return on equity (ROE) |
-22.2%
|
94.5%
|
10.7% |
Change turnover |
0
|
-5,088
|
-496 |
Change turnover % |
-100%
|
-10% | |
Chg. No. of employees |
0
|
-3
|
0 |
Chg. No. of employees % |
0%
|
-75%
|
0% |
Total value of public sale
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.